Braizon Therapeutics, Inc. is a bio-venture firm originating from the University of Tokyo and Tokyo Medical and Dental University with the aim of bringing about a paradigm shift in the fields of medicine and life science through the application and implementation of our own innovative technology for the delivery of drugs to the brain.